Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PINK vs. QAAGZX: which is better?

Bottom line

PINK vs QAAGZX: the short answer

PINK (Simplify Health Care ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 41% by weight.

But QAAGZX is far broader, holding 277 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.

PINK is cheaper at 0.51% vs 0.86% — a difference of $35 a year per $10,000 invested.

Over one year, PINK returned +24.1% vs +18.1% for QAAGZX.

Updated Nov 19, 2026

PINK vs QAAGZX side by side

PINKQAAGZX
TypeETFETF
Fund familySimplify Exchange TradedT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.51%0.86%
Annual cost per $10k$51$86
10-yr cost on $10k (prospectus)$641$1,061
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+24.1%+18.1%
5-yr return (annualized)—+4.1%
10-yr return (annualized)—+9.0%
Best quarter+15.6%+23.4%
Worst quarter−9.5%−15.8%
Net assets (fund)$358.6M$751.7M
Number of holdings54277
Portfolio turnover171%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPINKQAAGZXDifference
2025+24.1%+18.1%+6.0%
2024+8.9%+1.7%+7.2%
2023+3.8%+3.0%+0.8%
2022−4.3%−12.5%+8.2%

Source: Fund prospectus bar charts

Holdings overlap

12 of PINK's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingPINKQAAGZX
Eli Lilly & Company5.91%14.06%
Unitedhealth Group Inc5.76%5.88%
Johnson & Johnson5.45%6.64%
Abbvie Inc4.52%5.12%
Thermo Fisher Scientific Inc3.23%2.53%
Gilead Sciences Inc2.87%2.79%
Elevance Health Inc2.73%1.54%
Danaher Corp2.28%1.44%
Amgen Inc2.12%1.80%
Cvs Health Corp2.01%0.93%
Cardinal Health Inc1.78%1.04%
Vertex Pharmaceuticals Inc1.45%2.26%

Source: SEC Form N-PORT

PINK top 10

  1. Purecycle Technologies Inc — 6.89%
  2. United Therapeutics Corp — 6.86%
  3. Novo Nordisk A/s — 6.75%
  4. Eli Lilly & Company — 5.91%
  5. Unitedhealth Group Inc — 5.76%
  6. Warby Parker Inc — 5.46%
  7. Johnson & Johnson — 5.45%
  8. Jazz Pharmaceuticals Plc — 4.61%
  9. Abbvie Inc — 4.52%
  10. Biohaven Ltd — 4.32%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between PINK and QAAGZX?
PINK (Simplify Health Care ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 41% by weight. But QAAGZX is far broader, holding 277 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
Which is cheaper, PINK or QAAGZX?
PINK has the lower expense ratio (0.51%).
Should I own both PINK and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.